Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Alcohol and benzodiazepines effects on simulated driving
ACTRN12618000727246Phase 2Recruiting
- Sponsor
- Swinburne University of Technology
- Start
- Oct 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of alprazolam, temazepam, diazepam and ethanol in anxiety disorder and Insomnia (3 arms), sponsored by Swinburne University of Technology. Primary endpoints: Driving performance during simulated highway driving and Ocular activity while driving. Started Oct 2018; status: recruiting.
02
Drugs
alprazolamtemazepamdiazepamethanol
03
Conditions
anxiety disorderInsomnia
Beyond the preview
Go deeper on ACTRN12618000727246.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12618000727246.